Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease

Keyphrases

• Antibody Response 100%
• Progressive Disease 100%
• Cytokine Response 100%
• Infected Patients 100%
• Chemokine Responses 100%
• Stable Disease 100%
• Echinococcus multilocularis 100%
• Alveolar Echinococcosis 100%
• Metacestode 36%
• E. multilocularis 36%
• Eotaxin 18%
• Disease Progression 18%
• Interleukin-33 (IL-33) 18%
• Response Profiles 18%
• Interleukin-27 (IL-27) 18%
• Antibody Reactivity 18%
• Chemokine Ligand 12 (CXCL12) 18%
• IgG4-related Disease (IgG4-RD) 18%
• IL-31 18%
• Eotaxin-1 18%
• Eotaxin-2 18%
• Immune Response 9%
• Specific Antibodies 9%
• Parasite Antigens 9%
• Chemokines 9%
• Cellular Response 9%
• IgE Response 9%
• Organ Failure 9%
• Parasitic Diseases 9%
• IgG1 9%
• IgG3 9%
• IgG2 9%
• CCL11 9%
• Tapeworm 9%
• Eosinophilic Granulocyte 9%
• CCL24 9%
• Disease Regression 9%
• CCL26 9%

Immunology and Microbiology

• Antibody Response 100%
• Cytokine 100%
• Chemokine 100%
• Echinococcus multilocularis 100%
• Echinococcosis 100%
• Metacestode 36%
• Immunology 27%
• Eotaxin 18%
• Interleukin-33 18%
• Immunoglobulin G4 18%
• Eotaxin 3 18%
• Eotaxin 2 18%
• Immune Response 9%
• Parasite Antigen 9%
• Immunoglobulin E 9%
• Eosinophil Granulocyte 9%
• Cytokine Response 9%
• Chemokine Response 9%
• Parasitic Disease 9%
• Immunoglobulin G1 9%
• Immunoglobulin G3 9%
• Immunoglobulin G2 9%
• CCL11 9%
• Cestoda 9%
• CCL24 9%
• CCL26 9%
• Antibodies 9%
• Stromal Cell-Derived Factor 1 9%